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Human cytomegalovirus (HCMV) co-infection is highly prevalent within HIV-1 cohorts 
and is an important cofactor in driving ongoing immune activation, even during effective 
antiretroviral treatment. HCMV infection has recently been associated with expansion 
of adaptive-like natural killer (NK) cells, which harbor epigenetic alterations that impact 
on their cellular function and phenotype. The influence of HCMV co-infection on the 
considerable heterogeneity among NK cells and their functional responses to different 
stimuli was assessed in a cohort of HIV-1-infected individuals sampled during differ-
ent stages of infection, compared with healthy subjects stratified according to HCMV 
serostatus. Our data demonstrate a reshaping of the NK cell pool in HIV-1 infection of 
HCMV-seropositive individuals, with an accentuated peripheral transition of CD56dim 
NK cells toward a mature CD57+ CD85j+ NKG2C+ NKG2A− phenotype. Lack of PLZF 
further distinguishes adaptive NK cells from other NK cells expressing CD57 or NKG2C. 
PLZF− NK cells from HIV-infected individuals had high expression of CD2, were Siglec-7 
negative and exhibited downregulation of key signaling molecules, SYK and FcεRI-γ, 
overwhelmingly displaying features of adaptive NK  cells that correlated with HCMV 
serum Ab levels. Notably this adaptive-like signature was detected during early HIV-1 
infection and persisted during treatment. Adaptive-like NK cell subsets in HIV-1-infected 
individuals displayed enhanced IFN-γ production following Fc receptor triggering com-
pared with their conventional NK cell counterparts, and their ability to produce TNF-α 
and degra nulate was preserved. Together, these data suggest that HMCV infection/
reactivation, a hallmark of HIV-1 infection, plays a role in driving a relative expansion of 
NK cells with adaptive features during HIV-1 infection. The identification of selective NK 
subsets with retained effector activity in HIV-1-infected subjects raises the possibility 
of developing therapeutic strategies that exploit specific NK subpopulations to achieve 
better HIV-1 control.
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inTrODUcTiOn
Natural killer (NK) cells are a diverse subset of innate lymphocytes that play a key effector role in 
antiviral defense, especially against herpesviruses (1), and tumor surveillance (2), and also have 
important immunoregulatory functions (3). In animal models, NK cells have been shown to have the 
capacity to acquire immunological memory, a property traditionally ascribed to B and T cells (4, 5).
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A role for NK cells in HIV-1 infection is supported by epi-
demiological studies linking specific KIR/HLA combinations 
with HIV-1 infection outcome (6, 7), functional studies where 
protective KIR alleles are associated with enhanced NK  cell 
cytolytic function in  vitro (8) and evidence of HIV-1 having 
evolved strategies to evade NK  cell recognition (9). In addi-
tion to genetic contributions influencing the NK cell repertoire 
environmental factors, especially infections, exert a profound 
and cumulative influence shaping NK  cell diversity (10). 
Recent studies have shown that NK cells responding to murine 
CMV expand, forming a pool of long-lived memory cells that 
undergo robust recall responses (11). Human cytomegalovirus 
(HCMV) infection has also been linked with the identification 
of adaptive or memory-like NK cells in humans. These lasting 
expansions were originally characterized by higher frequencies 
of NKG2C+ NK  cells in HCMV-seropositive individuals and/
or in the context of acute HCMV infection or reactivation 
(12, 13). Such expansions have also been reported during acute 
and chronic viral infections including HIV-1, systematically 
associated with HCMV seropositivity (14). HCMV-adapted 
NK cells encompass heterogeneous populations characterized by 
a number of phenotypic attributes, not necessarily combined at a 
single-cell level or limited to the expression of NKG2C (15, 16). 
A degree of redundancy is evidenced by the detection of NK cell 
subsets sharing numerous phenotypic and functional attributes 
of adaptive NK cells in individuals independent of NKG2C or 
in the absence of NKG2C (KLRC2-deficient individuals) and in 
transplant recipients of NKG2C null grafts (16–18). Importantly, 
these so-called adaptive NK cells share epigenetic similarities to 
cytotoxic CD8 T  cells and are marked by DNA methylation-
dependent silencing of the transcription factor promyelocytic 
leukemia zinc (PLZF), as well as stochastic loss of expression of 
key proximal signaling molecules such as FcεRI-γ, spleen tyros-
ine kinase (SYK), or EWS/FLI1-activated transcript 2 (15, 19, 20). 
Adaptive NK  cells are functionally dichotomized, exhibiting 
reduced responsiveness to stimulation with IL-12/IL-18 and a 
bias toward Fc receptor-dependent functions and specializa-
tion in the immunosurveillance of infected cells, and may be 
important for HCMV control especially when T cell immunity 
is impaired (21).
A comprehensive analysis of the transcriptional signatures 
and epigenetic modifications of NK  cells in HIV-1 infection 
is currently lacking. Previous studies addressing the effects of 
HIV-1 infection on NK cell phenotypic and functional attributes 
do not always account for the confounding effect of HCMV, 
which is almost universal in HIV-1-infected cohorts and is an 
important cofactor associated with systemic inflammation, non-
AIDS complications and immune senescence (22, 23), as well as 
an important driver of NK  cell-associated changes (24). Here, 
we explored adaptive-like NK expansions during the course 
of HIV-1 infection, taking into account the likely influence of 
co-infection with HCMV. We also characterized NK effector 
responsiveness to various stimuli to identify novel NK cell “adap-
tive” signatures and preserved activation pathways that could be 
targeted for therapeutic purposes. Our data indicate a reshaping 




For cross-sectional analyses, PBMCs cryopreserved from 21 
untreated chronically HIV-1-infected Caucasian males from a 
London cohort were utilized. The London cohort was recruited at 
the Mortimer Market Center for Sexual Health and HIV Research 
(London, UK) following written informed consent as part of a 
study approved by the local ethics board committee. The cross-
sectionally studied individuals formed part of a historical cohort 
who presented with symptoms of acute retroviral infection and 
were followed-up longitudinally into chronic infection and post 
commencement of antiretroviral treatment (ART). The date of 
infection was estimated as 17 days before symptom onset, which 
we assumed to occur in Fiebig stage 2, i.e., in the phase of acute 
HIV-1 infection before the peak in viremia when HIV-1 RNA 
and p24 antigen can be detected in plasma but seroconversion 
has not yet started to occur (25). A subgroup of five individuals 
from whom early infection samples was also available, was used 
for longitudinal assessment of the NK cell repertoire from early 
to chronic to posttreatment time points. At the post-treatment 
time point, all subjects had been receiving ART continually for at 
least 12 months and had levels of viremia <50 RNA copies/mL. 
Twenty demographically age- and sex-matched HIV-1 seronega-
tive controls were used for comparison, from whom blood was 
taken and cryopreserved for later use with written informed 
consent in accordance with the Declaration of Helsinki. All 
study participants were anti-Hepatitis C virus antibody negative 
and anti HBsAg negative. HCMV serology was determined at 
University College London Hospital clinical virology lab by the 
ARCHITECT CMV IgG assay (AU/mL) (Abbott Diagnostics, IL, 
USA). Patient and healthy control characteristics are included in 
Tables S1 and S2 in Supplementary Material.
Monoclonal antibodies and Flow 
cytometric analysis
The following fluorochrome-conjugated antibodies were used 
in this  study: CD14 BV510, CD19 BV510, CD56 PE Dazzle, 
CD3 BV650, CD16 PERCP or CD16 BV711, CD38 BV785, NKG2D 
FITC, PD1 BV711 (BioLegend), NKp30 APC (Miltenyi), NKp46 
PE (BD Biosciences), CRACC Pe-Cy7, CD2 Pe-Cy7, Siglec-7 PE, 
2B4 APC (BioLegend), CD85j biotin (eBioscience) followed by 
Streptavidin-BV711 (BioLegend), CD4 APC-Cy7, CD8 Alexa700 
(eBioscience), NKG2A Pe-Cy7, KIR2DL2 APC CD158b1/b2.j 
APC (Beckman Coulter), NKG2C PE, KIR2DL1/2DS5 APC 
IgG1 (CD158a), KIR3DL2 APC (R&D Systems), CD57 BV421 
(BD Biosciences), KIR3DL1 APC (CD158e1) (Miltenyi), for 
surface antigens; CD3ζ, Syk PE (BD Biosciences), Perforin PE 
(BioLegend), IFN-γ BV421 (BD Biosciences), TNF-α BV711 
(BioLegend), FcεRI-γ-FITC (Millipore) for intracellular stain-
ing; and PLZF-APC (BD Biosciences) for intranuclear staining. 
Briefly, cryopreserved PBMC isolated from HIV-1-infected 
patients and healthy donors were washed in PBS, and surface 
stained at 4°C for 20 min with saturating concentrations of dif-
ferent combinations of antibodies in the presence of fixable live/
dead stain (Invitrogen). Cells were then fixed and permeabilized 
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for detection of intracellular antigens. The Foxp3 intranuclear 
staining buffer kit (eBioscience) was used according to the 
manufacturer’s instructions for the detection of intranuclear 
markers. Samples were acquired on a BD Fortessa X20 using BD 
FACSDiva8.0 (BD Bioscience) and data analyzed using FlowJo 10 
(TreeStar). Stochastic neighbor embedding (SNE) analysis was 
performed using the mrc.cytobank platform. The t-distributed 
stochastic neighbor embedding algorithm clusters cells according 
to expression of multiple parameters and enables visualization 
of high-dimensional data in two-dimensional representations 
(single-cell spatial groupings), avoiding the bias that can be intro-
duced by manual gating of specific subsets (26). For concatenating 
multiple FCS files into a single FCS file, the FCS file concatenation 
tool was used before uploading the files to cytobank. NK cells were 
identified based on CD3, CD56 and CD16 expression. For the 
panel of differentiation markers the viSNE calculation was based 
on the parameters PLZF, FcεRI-γ, CD2, and Siglec-7.
Functional assays
For target cell stimulation PBMC were incubated with K562 
cells (5:1 E:T ratio) for 6 h at 37°C in the presence of CD107a-
APC-Cy7 antibody (BD Biosciences, Cowley, UK) and GolgiStop 
(containing Monensin, 1/1,500 concentration, BD Biosciences). 
To assess responses to stimulation with cytokines, PBMC were 
incubated with 10  ng/mL of rhIL-12 (PeproTech) and 100  ng/
mL rhIL-18 (R&D Systems, Abingdon, UK) for 18  h at 37°C. 
GolgiStop (containing Monensin, 1/1,500 concentration, BD 
Biosciences) and GolgiPlug (containing brefeldin A, 1/1,000 
final concentration, BD Biosciences) were added for the last 3 h of 
culture in experiments where intracellular IFN-γ was a read-out. 
Where indicated stimulation of PBMC with phorbol 12-myristate 
13-acetate (PMA) (3  ng/mL), and ionomycin (100  ng/mL) 
(Sigma) was performed for 6 h.
For activation via CD16 cross-linking, 96-well flat-bottom 
plates (Nunc) were coated with 5 μg/ml antihuman CD16 (clone 
3G8, BD Biosciences) or an isotype-matched control antibody 
(mIgG1κ, BD Biosciences) overnight at 4°C. Plates were washed 
with sterile PBS before addition of 4 × 105 PBMC per well. Cells 
were incubated for 6 hrs in the presence of CD107a-APC-Cy7 
antibody (BD Biosciences, Cowley, UK). GolgiStop (contain-
ing Monensin, 1/1,500 concentration, BD Biosciences) and 
GolgiPlug (containing brefeldin A, 1/1,000 final concentration, 
BD Biosciences) were added for the last 5 h of culture. Following 
incubation cells were washed and stained for extracellular recep-
tors before permeabilization and intracellular staining for TNF-α 
and IFN-γ.
Dna Methylation analysis
Genomic DNA was isolated using the DNeasy Blood and Tissue 
kit (QIAGEN). The methylation levels of seven CPG residues 
within the IFNG CNS1 region were analyzed via bisulfite conver-
sion and pyrosequencing by Epigendx, Inc. The Human IFNG 
methylation assay ADS2902-FS1 (−4,394 to −4,355 from TSS) 
and ADS2902-FS2 (−4,320 to −4,224 from TSS) distal promoter 
(CNS1) were used. Donors were selected based on the size of the 
target subsets to ensure sufficient numbers of cells for methyla-
tion analysis after sorting.
Data analysis
Prism 7 (GraphPad Software) was used for all statistical analysis 
as follows: the Mann–Whitney U-test or Student’s t-test were used 
for single comparisons of independent groups, the Wilcoxon-test 
was used to compare two paired groups, Kruskal–Wallis with 
Dunn’s multiple comparison test was used to compare three 
unpaired sample groups, and Friedman test was used for multiple 
comparison of paired samples. The non-parametric Spearman 
test was used for correlation analysis. Permutation tests were per-
formed in SPICE version 5.32 (*p < 0.05, **p < 0.01, ***p < 0.001, 
and ****p < 0.0001).
resUlTs
skewing of the nK cell repertoire toward 
a Mature/Terminally Differentiated 
Phenotype during Viremic hiV-1 infection
Changes in expression of NK  cell receptors (NKRs) compared 
with those in healthy volunteers have been reported in viremic 
HIV-1 infection (27, 28), but the HCMV serostatus of the sub-
jects studied has not always been taken into consideration. We 
explored the diversity of NK cell phenotypes in a unique cohort 
of n =  21 HIV-1-infected male Caucasian individuals (n =  20 
HCMV-seropositive, n = 1 HCMV seronegative) recruited dur-
ing acute infection and followed-up longitudinally both pre- and 
post-initiation of antiretroviral therapy, and compared with two 
groups of n = 10 HCMV-seropositive and n = 10 HCMV seron-
egative HIV-1 seronegative age matched male Caucasian controls 
(Tables S1 and S2 in Supplementary Material). We confirmed the 
effects of HIV-1 viremia on the pathological redistribution of 
the NK cell compartment with a reduction in frequencies of the 
CD56dim subset and the emergence of an aberrant CD56−CD16+ 
NK cell subset as previously described (29, 30) compared with 
the HIV-1 seronegative controls and irrespective of their HCMV 
serostatus (Figures 1A–C).
Given that HCMV infection induces a highly differentiated 
phenotype within the CD56dim subset we assessed the surface 
expression of NKG2C/A, KIRs (focusing on mainly in inhibi-
tory KIRs using a cocktail of antibodies against KIR2DL1/S5, 
KIR2DL2/L3/S2, KIR3DL2, and KIR3DL1), CD85j/LIR-1 and 
the terminal differentiation marker CD57 on this subset in rela-
tion to HCMV serostatus in the entire study cohort. HCMV sero-
positivity in both HIV+ and HIV− subjects was associated with 
a higher frequency of CD56dim NK cells expressing NKG2C and 
lower expression of NKG2A compared with HCMV  seronegative 
controls (Figure  1D). A broader range of NKG2C expression 
was observed in the HIV-1-infected individuals compared with 
the HIV-1 seronegative HCMV-seropositive controls (range 
1.89–81.1 versus 0.263–30.6) likely suggesting higher HCMV 
burden/reactivation in the former group (31). Higher levels of 
CD85j were associated with HIV/HCMV co-infection, consist-
ent with reports supporting a role in influencing the long-term 
responses of CD85j+ NK cells during HCMV dissemination (32). 
HCMV serostatus did not significantly alter the expression of 
KIRs (Figure 1D). Expression of CD57 did not differ between the 
three groups, demonstrating the presence of NK cells at different 
FigUre 1 | Subset redistribution and NK cell receptor (NKR) expression according to human cytomegalovirus (HCMV) serostatus. (a) Representative example 
gated on live CD3− CD4− lymphocytes; CD56 and CD16 are used to identify natural killer (NK) cells, discriminating between populations on the basis of 
CD56bright, dim, and negative expression levels. (B) Representative example of NK cell subset distribution in a healthy control versus a HIV-1-infected individual. 
(c) Summary box plots of the frequencies of CD56bright, CD56dim, and CD56neg NK cell subsets among HIV-1-uninfected HCMV− (CTR CMV−), HIV-1-
uninfected HCMV+, and HIV-1-infected individuals. Red filled circles denote CTR CMV− subjects, open circles denote CTR CMV+, blue open circles denote 
HIV-1-infected HCMV+ individuals, and the single-filled blue dot denotes the HIV-1-infected HCMV− subject. (D) Summary data for the expression of NKRs as 
shown in the CD56dim subset for the three groups studied. Significance determined by the Mann–Whitney test for comparison between groups (*p < 0.05, 
**p < 0.01, and ****p < 0.0001).
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stages of differentiation (Figure  1D). However, Boolean gating 
analysis for the expression of NKG2A/C, CD85j, and KIRs within 
the CD57+ fractions of CD56dim NK  cells revealed a higher 
percentage of NK cells that were CD85j+ KIR+ NKG2C+ and a 
reduction of the early mature KIR+ NKG2A+ NK cells in the HIV-
1-infected individuals compared with both HIV-seronegative 
control groups; this difference was more pronounced when 
compared with the HIV-seronegative HCMV-seropositive group 
(Figures 2A–C). These data are consistent with a more prominent 
skewing of the NK  cell repertoire toward a terminally mature 
phenotype driven by HCMV co-infection within the HIV-1-
infected individuals. This is further supported by downregulation 
of NCRs (NKp30 and NKp46) in HIV-1-infected individuals, but 
comparable levels of NKG2D and SLAMF receptors between the 
groups (Figure S1A in Supplementary Material).
The temporal evolution of the NK cell repertoire was examined 
in selected individuals (n = 5) from whom samples were available 
during early infection, established viremic infection and at least 
1-year post successful antiretroviral-associated viral control. Our 
analysis revealed that receptor changes evident in early infection 
persist during chronic disease and in the first year post successful 
ART (Figures S1B,C in Supplementary Material).
gradual shift in the Functional 
responsiveness of the cD56dim nK cell 
subset with increasing Differentiation
Focusing on NKG2A and KIRs as key markers in the dynamic 
process of terminal differentiation within the CD56dim subset we 
assessed the ability of CD56dim NK cell subsets at diverse differ-
entiation stages to degranulate following stimulation with K562 
(HLA class I devoid) targets. No differences were seen between 
groups in the ability of CD56dim NK cells and subsets to degran-
ulate on exposure to HLA-I negative targets (Figures 3A,B); the 
CD56dim NKG2A-KIR− NK cells exhibited significantly lower 
degranulation against K562 targets cells than the other CD56dim 
subsets, as previously described (33). Next we evaluated the 
ability of the CD56dim subset to produce IFN-γ in response 
to stimulation with IL-12/18. Despite a trend for lower IFN-γ 
production in the HIV-1-infected individuals, no significant 
FigUre 2 | Increased peripheral transition toward a mature CD56dim phenotype in HIV-1 infection. (a) Representative contour plots depicting the gating strategy 
for the expression of CD85j, KIRs, and NKG2A/2C within the CD57-positive CD56dim subset for the three study groups. (B) SPICE analysis (bar charts) of 
combinations of CD85j, KIRs, NKG2A, and NKG2C within the CD57+ fraction of CD56dim natural killer cell subset between HIV-1 seronegative human 
cytomegalovirus (HCMV) seronegative n = 10 (CTR CMV−), HIV-1 seronegative HCMV-seropositive n = 10 (CTR CMV+), and HIV-1-infected HCMV-seropositive 
n = 20 (HIV-1+ CMV+) individuals. (c) SPICE analysis pie charts for each group. Each colored pie slice corresponds to the different receptor combinations shown. 
The pie arcs depict individual receptor expression. A permutation test was performed between pie charts (*p < 0.05 and ***p < 0.001). Student’s t-test was used to 
compare samples in SPICE (#p < 0.05).
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difference was observed in the overall cytokine responsiveness 
of total CD56dim NK cells between the groups (Figure 3C). This 
may reflect the relatively small size of the control groups and/or 
the fact that HIV-1 infection was not extremely advanced (mean 
days since diagnosis with acute seroconversion =  764.5, mean 
CD4 = 482) in our study group. However, IL-12 and IL-18 co-
stimulation induced significantly less IFN-γ production by the 
NKG2A-KIR+ subset relative to all other NK cell subsets espe-
cially within HCMV-seropositive HIV-1-infected subjects, in 
whom there is enrichment of more terminally mature CD56dim 
NK  cells (Figure  3D). This is in keeping with the reported 
reduced expression of cytokine IL-12Rβ2 and IL-18Rα receptors 
with increasing status of NK cell maturation (34). NK cells did 
not have an intrinsic defect in cytokine production, as shown by 
the comparable ability of total CD56dim NK cells and subsets, 
defined on the basis of NKG2A and KIR expression, to produce 
IFN-γ in response to phorbol 12-myristate 13-acetate (PMA) and 
ionomycin (I) stimulation (Figures 3E,F).
adaptive cD56dim nK cells in hiV-1 
infection are characterized by Marked 
Downregulation of PlZF
To determine to what extent the above phenotypic and functional 
perturbations reflect the presence of adaptive NK cells within the 
CD56dim subset in our HIV-1-infected cohort we extended our 
phenotypic analysis to encompass expression of the transcription 
factor PLZF, expression of which is reduced in HCMV+ individu-
als, denoting the presence of adaptive NK cells (15). We detected 










































































FigUre 3 | Changes in functionality with differentiation of CD56dim natural killer (NK) cells. Summary bar charts of (a) CD107a expression by total CD56dim 
NK cells and (B) subsets thereof distinguished on the basis of the expression of NKG2A and KIRs in the three study groups. (c) Summary bar charts showing 
expression of IFN-γ by total CD56dim NK cells and (D) subsets thereof following stimulation with a combination of IL-12/IL-18. (e) Summary bar charts of IFN-γ 
production by total CD56dim NK cells and (F) subsets thereof following stimulation with PMA/I. Bars show mean ± SEM. The non-parametric Mann–Whitney U-test 
was used to compare data between groups (*p < 0.05).
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subset in the HIV-1-infected HCMV-seropositive individuals 
compared with HIV-1-seronegative HCMV-seropositive controls 
(Figures 4A,B). The levels of PLZF expression correlated nega-
tively with serum HCMV Ab titers (Figure 4C). Next we looked 
at the expression levels of the adaptor protein FcεRI-γ, since a 
population that lacks FcεRI-γ expression has been found to be 
strongly associated with HCMV seropositivity and has also been 
identified in HIV-1 viremic individuals (35, 36). There was no sta-
tistically significant difference between the levels of expression of 
FcεRI-γ in HIV-1-infected HCMV seropositive individuals and 
HIV-1 seronegative HCMV-seropositive controls (Figures 4D,E) 
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FigUre 4 | Transcriptional signature of the CD56dim natural killer (NK) population and subsets thereof in human cytomegalovirus (HCMV)-seropositive HIV-infected 
and -uninfected subjects. (a) Representative plots of PLZF expression in CD56dim NK cells from an HIV-1 negative HCMV+ individual and an HIV-1-infected 
HCMV+ individual and (B) summary data from n = 10 HIV-1-infected HCMV+ subjects (HIV-1+ CMV+) and n = 9 HIV-1 negative HCMV+ controls (CTR CMV+). 
(c) Correlation between PLZF expression levels and available HCMV Ab titers (black circles CTRCMV+, blue filled circles HIV-1+ CMV+, and red filled circle single 
HIV-1+ CMV−). (D) Representative plots of FcεRI-γ expression in CD56dim NK cells from a HIV-1 negative HCMV+ individual and a HIV-1-infected HCMV positive 
individual and (e) summary data. (F) Example of PLZF/FcεRI-γ co-expression in a representative HIV-1-infected HCMV+ individual (blue contour) and the 
HIV-1-infected HCMV− individual (in red). Results are expressed as mean ± SEM (***p < 0.001) by Mann–Whitney test. The non-parametric Spearman test was 
used for correlation analysis.
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p = 0.0572 and r = −0.4882). Notably the single HCMV− HIV-
1-infected individual displayed high expression of PLZF (77.1%) 
and moderate expression of FcεRI-γ (56.5%) (Figure 4F).
Phenotypic Profile of PlZF− cD56dim  
nK cells in hiV-1 infection
To examine the nature of the PLZF− subset in relationship to 
the PLZF+ subpopulation, we performed a detailed evaluation 
of their phenotypic attributes. PLZF− CD56dim NK  cells in 
HIV-1-infected individuals exhibited coordinated changes in 
the expression of a number of molecules, some of which have 
been previously associated with the differentiation status and 
adaptive-like phenotype of NK cells (Figure 5A). We observed 
significantly increased expression of CD57 (p =  0.020), CD85j 
(p = 0.0010), KIRs (p = 0.0312), and CD2 (p = 0.0010) within the 
PLZF− subset relative to the PLZF+ subset. By contrast there was 
a significant under-representation of NKG2A (p = 0.0020), CD7 
(p = 0.0010), Siglec-7 (p = 0.0010), and CD38 (p = 0.0371) within 
the PLZF− subset, in keeping with a more mature and adaptive-
like phenotype. A non-statistically significant trend for higher 
expression of NKG2C in the PLZF− subset (p = 0.0557) was seen, 
suggesting that not all NKG2C+ NK  cells possess an adaptive 
signature. No difference was detected in the intracellular levels of 
perforin (p = 0.6250) between the two subsets. Equally there was 
no significant decrease in the levels of Helios in the PLZF− versus 
PLZF+ subset (p =  0.7002), consistent with observations that 
Helios does not appear to be uniformly downregulated in human 
adaptive NK cells (15).
PLZF can initiate changes in DNA methylation and is known 
to interact with the promoter regions of FcεRI-γ and Syk. 
Accordingly FcεRI-γ− and Syk− NK cell subsets were enriched 
within the PLZF− NK cell population (p = 0.0010 and p = 0.0059, 
respectively) (Figures  5B,C). CD3ζ levels were comparable 
between the two subsets, in line with reports demonstrating that 
PLZF does not bind the promoter of the gene encoding CD3ζ 
(Figure  5D) (15). Similar changes were observed in the two 
subsets from healthy HIV-1 seronegative HCMV-seropositive 
individuals (data not shown). A more striking downregulation 
of Siglec-7 and upregulation of CD2 was, however, noted in total 
CD56dim and NK  cell subsets in HIV-1-infected individuals 
compared with HIV-1-uninfected HCMV-seropositive controls 
(p < 0.0001 and p = 0.0074, respectively, data not shown) and 
within the PLZF− fractions (Figures  5E,F). The expression of 
CD2 in the PLZF− fraction of NK  cells correlated positively 
with CMV Ab levels (r =  0.7053, p =  0.0007). No correlation 
was observed between expression of Siglec-7 and CMV Ab titers 
(r = −0.16, p = 0.5261). Interestingly, the single HIV-1-infected 
HCMV seronegative patient had decreased expression of Siglec-7 















































































FigUre 5 | Phenotypic profiles of PLZF− CD56dim natural killer (NK) cells in HIV infection. (a) Heat map representation of the mean level of expression 
(mean + SD) of the receptors shown within the PLZF− and PLZF+ CD56dim NK cell subsets from n = 10 HIV-1-infected HCMV+ individuals. Paired data showing 
proportion of FcεRγ expressed (B) and MFI of Syk (c) and CD3ζ (D) on PLZF− and PLZF+ CD56dim NK cell subsets from n = 10 HIV-1-infected HCMV+ 
individuals. (e,F) Bar charts showing proportion of Siglec-7 (e) and CD2 (F) expressed on PLZF− CD56dim NK cells in HIV-1-uninfected HCMV+ individuals 
(PLZF-CTR) and HIV-1-infected individuals (PLZF-HIV-1−). Significance determined by the Mann–Whitney test for comparison between groups and the Wilcoxon 
signed rank test for paired data (**p < 0.01).
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expression in HIV-1+ HCMV+ individuals) and the lowest 
level of expression of CD2 (71.5% versus mean expression 86.4% 
within the HIV-1+ HCMV+ individuals).
A subpopulation of PD1+ NK cells, comprised of fully mature 
NK cells, has been recently described in HCMV+ individuals (37). 
We detected a modest increase in the levels of PD1 expression 
within the PLZF− subset of NK cells in HIV-1-infected individu-
als (Figures S2A,B in Supplementary Material). The two individu-
als with the highest levels of PD1 expression had a lower CD4 
count (mean = 190), higher HIV-1 viral load (>100,000 copies/
mL) and a more prolonged course of disease (mean = 1,535 days 
since seroconversion).
adaptation of the cD56dim nK cell 
compartment to hcMV results in stable 
imprints during the course of hiV-1 
infection
To examine the longitudinal changes in NK cell subsets with an 
adaptive signature in HIV-1 infection we compared the expres-
sion of Siglec-7, CD2, FcεRI-γ, and PLZF in CD56dim NK cells 
during early, established infection and post-ART in 5 individuals. 
In addition to flow cytometric analysis we employed non-linear 
dimensionality reduction using t-SNE (26). This enabled us to 
visualize high-dimensional data in two-dimensional representa-
tions and circumvent any bias introduced by manual gating. 
Analysis revealed clear clusters of cells sharing low expression of 
Siglec-7, FcεRI-γ, and PLZF and high CD2 expression (Figure 6A). 
Importantly, these changes were apparent during early infection, 
were more pronounced during established chronic infection, 
and were maintained after successful ART (Figure  6B), with 
the exception of Siglec-7, which demonstrated some recovery of 
expression in the PLZF+ subset (Figure 6C). A non-significant 
trend toward even lower levels of FcεRI-γ was observed dur-
ing treatment (Figure  6B). PLZF can initiate changes in DNA 
methylation and interacts with the promoter regions of FcεRI-γ 
and several other target genes (15), explaining the stability of the 
adaptive signature after treatment. This is further supported by a 
recent report indicating that 2 years of successful ART does not 
reverse CD56dim FcεRγ− NK cell expansion (36).
Functional correlates of cD56dim nK 
cells with an adaptive signature in hiV-1 
infection
Finally, we sought to investigate the functional consequences of 
the observed alterations in the NK cell signaling and transcrip-
tion factors. Given the importance of antibody-dependent cel-
lular cytotoxicity (ADCC) in the control of HCMV, we analyzed 
the Fc receptor-dependent activation of adaptive NK  cells in 
response to plate bound anti-CD16 stimulation. The percentage 
of total CD56dim NK  cells from HIV-1-infected individuals 
producing IFN-γ in response to stimulation was significantly 
lower than that in HIV-1 seronegative HCMV-seropositive 
individuals (Figure 7A), with less marked effects being observed 
on TNF-α production and degranulation (Figures 7B,C). As a 
potential mechanism explaining the overall reduced proportion 













































FigUre 6 | Stability of CD56dim transcriptional signature during HIV-1 infection. (a) viSNE analysis of multiparametric data was performed on CD56dim natural 
killer (NK) cells from five compiled HIV-1-infected donors during early and chronic infection and post-antiretroviral (ART). Representative data from a HIV-1-negative 
HCMV-negative (CTR CMV−) and composite data from 9 HIV-1-negative HCMV-positive control individuals (CTR CMV+) are shown for comparison. For better 
visualization of the intensity of expression of Siglec-7, the Siglec-7+ population was selected. Each point in the viSNE map represents an individual cell. Colors 
depict intensity of protein expression. (B) Heat maps of levels of expression (mean + SD) of PLZF, FcεRI-γ, CD2, and Siglec-7 in n = 5 HIV-1-infected HCMV+ 
individuals and n = 9 HIV-1-uninfected HCMV+ controls. (c) Heat map representation of the levels of expression of Siglec-7 within the PLZF− and PLZF+ fractions 
of NK cells.
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expression of CD16 (Figures S3A,B in Supplementary Material), 
which correlated positively with IFN-γ production (r = 0.5573, 
p = 0.0132), suggesting that CD16 downregulation or shedding 
during chronic HIV-1 infection may impair the overall functional 
ability of NK cells. Despite the overall reduction in IFN-γ produc-
tion, the fold change in the capacity of PLZF−/PLZF+ subsets 
to produce IFN-γ was greater in the HIV-1-infected individuals 
compared with HCMV+ HIV-1− controls (Figure 7D) in whom 
canonical PLZF+ NK cells displayed higher production of IFN-γ 
after cross-linking (Figure S3C in Supplementary Material). A 
similar trend was observed for TNF-α production, although the 
degranulation capacity of PLZF−/PLZF+ subsets did not differ 
(Figures 7E,F). The enhanced ability of the PLZF− subset, which 
is enriched in the HIV-1-infected group, to produce IFN-γ is in 
keeping with a more hypomethylated and hence accessible region 
of the CNS1 region of the IFN-γ locus in the adaptive PLZF− 
NK cells (Figure 7G).
DiscUssiOn
This study demonstrates that viremic HIV-1-infected patients 
manifest phenotypic and functional perturbations in their 
NK cell compartment consistent with an adaptive reconfigura-
tion driven in part by underlying co-infection with HCMV, an 
almost ubiquitous pathogen in HIV-1-infected cohorts and a 
recognized cofactor associated with ongoing immune activation. 
The complex interplay between HCMV and HIV-1 likely leads 
to the establishment of a predominantly adaptive-like CD56dim 
NK cell profile further delineated by a stronger downregulation of 
the transcription factor PLZF (thought to mark adaptive NK cells 
in humans (15)), compared with HIV-1-uninfected HCMV-
seropositive individuals. The PLZF− NK  cell subset in HIV-1 
infection was found to be enriched in markers denoting matura-
tion, and to have an enhanced capacity for IFN-γ production.
The factors accelerating the acquisition of a fully mature 
CD56dim CD57+ KIR+ NKG2C+ CD85j+ NKG2A− phenotype 
during HIV-1 infection in comparison with HIV-1-HCMV− 
individuals and driving a greater loss of PLZF expression in 
HIV-1-infected patients compared with HIV-1-uninfected 
HCMV-seropositive controls remain unclear. The potential 
role of HCMV as a driving force behind the acquisition of an 
adaptive NK phenotype during HIV infection is suggested by 
the fact that PLZF levels correlated in a negative fashion with 
HCMV Ab titers. The PLZF− CD56dim subset in HIV-1-infected 
individuals was distinguished by more pronounced upregulation 
of CD2 and downregulation of Siglec-7 compared with HIV-1-
uninfected HCMV-seropositive individuals. CD2, a co-activating 
receptor, synergizes with CD16 to boost cytokine production in 
adaptive NK cells (16). CD2 expression also correlated positively 
with CMV Ab levels, raising the possibility that CD2, through 
its recognition of its ligand CD58 on HCMV-infected cells, 
may influence the shaping of adaptive NK cells by providing a 
FigUre 7 | Functional responses of CD56dim subsets to CD16 triggering. (a–c) Summary bar charts of IFN-γ, TNF-α, and CD107a production by CD56dim 
natural killer (NK) cells from human cytomegalovirus (HCMV)-seropositive HIV-1-uninfected and -infected individuals. (D–F) Summary bar charts of fold change in 
IFN-γ, TNF-α, and CD107a production between PLZF−/PLZF+ NK cells in HCMV-seropositive HIV-1-uninfected n = 9 and -infected individuals n = 10. Bars 
mean ± SEM. Significance determined by the Mann–Whitney test for comparison between groups, *p < 0.05. (g) Bar graphs showing the mean percentage ± SD 
of methylation detected at each individual site of the IFNG CNS1 locus in PLZF+ (white bars) and PLZF− (black bars) NK cell subsets from n = 3 HIV-1/HCMV+ 
infected individuals.
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co-stimulatory signal. Siglec-7, an inhibitory receptor expressed 
constitutively on all NK cell subsets, is thought to participate in 
the regulation of cell function and survival (38). In addition to the 
global downregulation of Siglec-7 on CD56dim NK cells previ-
ously reported both in HIV-1 infection (39, 40) and in HSCT 
patients reactivating HCMV (41), we detected a more profound 
loss of Siglec-7 within the PLZF− subset in HIV-1 infection. It has 
been suggested that cumulative exposure to high levels of HIV-1 
viral replication may induce Siglec-7 shedding from the surface 
of NK  cells (42). More recently downregulation of Siglec-7 on 
activated PBMCs was reported under diabetogenic and inflam-
matory conditions (43). Thus systemic inflammation and meta-
bolic abnormalities during HIV-1 infection could modulate the 
expression of this receptor. Differentiation of adaptive NK cells 
is also driven by inflammation in animal models, and NK cells 
can display memory-like responses secondary to cytokines (44). 
Together, these data suggest that a combination of ongoing 
immune activation, higher infectious burdens including HCMV 
and progressive immune dysregulation could contribute to the 
higher expansions of NK  cells with adaptive features in HIV-
1-infected individuals. Importantly these phenotypic changes 
persist during ART especially within the PLZF− subset, which 
may reflect stable epigenetic modifications and the continuous 
influence of ongoing immune activation despite ART.
The functional capacities of distinct NK cell subsets in HIV-1 
infection are consistent with changes observed with increased 
differentiation (33). The enhanced capacity of the PLZF− NK cell 
subset for IFN-γ production compared with conventional PLZF+ 
NK  cells in HIV-1 infection, and in comparison with HIV-1 
negative HCMV-seropositive controls, is reflective of the greater 
magnitude of PLZF− NK  cells, and suggests a more restricted 
specificity toward CD16 triggering and cytokine production. The 
increased IFNG CNS1 accessibility could provide a molecular 
mechanism underlying more potent IFN-γ production following 
engagement of CD16. Moreover in PLZF− adaptive NK  cells, 
which lack FcεRI-γ, CD16 stimulation could mediate increased 
downstream signaling through association with CD3ζ homodi-
mers containing a total of six ITAMs (CD3ζ was expressed at 
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comparable levels between adaptive and conventional NK  cell 
subsets). FcεRI-γ− NK  cells isolated from HIV-1+ individuals 
have been shown to respond robustly when stimulated with 
HIV peptides in the presence of heterologous HIV+ serum (35). 
The overall reduction in the activity of CD56dim NK cells fol-
lowing CD16 triggering in our HIV-1-infected individuals was 
associated with differences in ex vivo CD16 expression levels, in 
keeping with previous reports of impaired ADCC function with 
progressive disease (45). This could be attributable to elevated 
MMP expression and activity during chronic HIV-1 infection 
(45). Interestingly in this small cohort we did not observe a 
significant reduction in the anti-CD16 degranulation response in 
the HIV-1-infected individuals. It is plausible that different CD16 
signaling thresholds exist for degranulation versus cytokine 
production (46) along with additional regulatory mechanisms. 
Nonetheless the identification of a subset with retained ability 
to respond to Fc-triggering in HIV-1 infection has potentially 
important implications for the design of therapeutic vaccines 
aimed at generating ADCC-promoting antibody responses. In 
future, it will therefore important to examine the size of adaptive 
NK cell populations in larger, demographically diverse cohorts 
and gain further insight into the role of signaling via CD16 and 
HIV-1 antibody-dependent NK cell activation and cytotoxicity as 
putative mechanisms for viral control (47).
While the expansion of adaptive NK  cells may serve a role 
in protective immunity against HCMV, important questions 
remain as to their role in conferring protection against HIV-1 
acquisition and how their presence impacts on HIV-1 control 
following infection. A beneficial role for adaptive NK cells has 
been suggested in both heterologous infection (20) and leukemia 
(48). We were not able to explore whether PLZF− NK  cells 
exhibited an enhanced ability to kill HIV-infected cells due to 
insufficient sample availability. Nonetheless mature or expanded 
NKG2C+ NKG2A− NK cells have been associated with a better 
early response to ART, low HIV viral setpoint and superior anti-
HIV capacity (49, 50). The converse observations of positive and 
negative correlations between NKG2C+ and NKG2A+ NK cells, 
respectively, and HIV-1 viral load during chronic infection (51) 
may be explained by evolving dysregulation and NK exhaustion 
during chronic infection, in line with which we observed a mod-
est increase of PD1 expression confined to the PLZF− subsets in 
individuals with more advanced HIV-1 disease.
Our findings reconcile some of the discrepancies in the 
published literature, demonstrating the clear footprint of HCMV 
co-infection on NK  cell phenotype during HIV-1 infection. 
However, a number of other factors, including the degree of 
immunosuppression and underlying level of pro-inflammatory 
cytokines during HIV-1 infection, could further shape the NK cell 
repertoire and accentuate the magnitude of these changes. The 
possibility for careful manipulation of specific NK  cell subsets 
with unique properties to achieve better HIV-1 control is an 
exciting avenue for further investigation. However, these attempts 
need to be tempered with the potential reduced tonic signaling 
from activating receptors in adaptive NK cells, which could influ-
ence their immunoregulatory and tumor surveillance role.
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